Flexeril and Irbesartan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Flexeril (cyclobenzaprine hydrochloride) and Irbesartan (irbesartan). Common drug interactions include device failure among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Flexeril and Irbesartan. It is created by eHealthMe based on reports of 57 people who take the same drugs from the FDA, and is updated regularly.

What is Flexeril?

Flexeril has active ingredients of cyclobenzaprine hydrochloride. It is often used in muscle spasms. eHealthMe is studying from 38,308 Flexeril users. Check the latest studies of Flexeril.

What is Irbesartan?

Irbesartan has active ingredients of irbesartan. It is often used in high blood pressure. eHealthMe is studying from 36,414 Irbesartan users. Check the latest studies of Irbesartan.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 24, 2026

57 people who take Flexeril and Irbesartan together, and have interactions are studied.

Flexeril and Irbesartan drug interactions.

What are the common drug interactions of Flexeril and Irbesartan, by gender? *:

female:

  1. Device failure
  2. Dizziness
  3. Dyspnoea (difficult or laboured respiration)
  4. Dysstasia (difficulty in standing)
  5. Fall
  6. Gait disturbance
  7. Hand fracture
  8. Loss of consciousness
  9. Nausea (feeling of having an urge to vomit)
  10. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)

male:

  1. Asthenia (weakness)
  2. Renal failure (kidney dysfunction)
  3. Deafness
  4. Depression
  5. Diastolic dysfunction
  6. Dyspnoea (difficult or laboured respiration)
  7. Erythema (redness of the skin)
  8. Gait disturbance
  9. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  10. Malaise (a feeling of general discomfort or uneasiness)

What are the common drug interactions of Flexeril and Irbesartan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest)

40-49:

  1. Acute myocardial infarction (acute heart attack)
  2. Asthenia (weakness)
  3. Atrioventricular block first degree (heart block first degree)
  4. Dizziness
  5. Fatigue (feeling of tiredness)
  6. Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
  7. Diastolic dysfunction
  8. Abdominal pain
  9. Abdominal pain upper
  10. Atelectasis (partial or complete collapse of the lung)

50-59:

  1. Chronic kidney disease
  2. Nephrogenic anaemia (anaemia due to kidney disease)
  3. Renal failure (kidney dysfunction)
  4. Blood cholesterol increased
  5. Blood glucose increased
  6. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  7. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  8. Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
  9. Gait disturbance
  10. Henoch-schonlein purpura (inflammation of the blood vessels in the skin and other body organs)

60+:

  1. Asthenia (weakness)
  2. Diarrhoea
  3. Dizziness
  4. Dyspnoea (difficult or laboured respiration)
  5. Dysstasia (difficulty in standing)
  6. Fall
  7. Hand fracture
  8. Loss of consciousness
  9. Memory impairment
  10. Renal failure (kidney dysfunction)

What are the existing conditions these people have? *

  1. High Blood Cholesterol: 11 people, 19.30%
  2. Pain: 10 people, 17.54%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 12.28%
  4. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 10.53%
  5. Stress And Anxiety: 5 people, 8.77%
  6. Blood Pressure Abnormal: 5 people, 8.77%
  7. Depression: 5 people, 8.77%
  8. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 4 people, 7.02%
  9. Asthma: 4 people, 7.02%
  10. Sleep Disorder: 4 people, 7.02%

* Approximation only. Some reports may have incomplete information.

Do you take Flexeril and Irbesartan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Flexeril and Irbesartan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Flexeril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Irbesartan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Flexeril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Irbesartan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cyclobenzaprine hydrochloride and irbesartan (the active ingredients of Flexeril and Irbesartan, respectively), and Flexeril and Irbesartan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: